Molecularly Targeted Therapy for Malignant Brain Tumors

Neuro−oncology is focusing on the uses of molecularly targeted agents in the adjuvant setting.

CME credit is no longer available for this conference.

Nicole A. Shonka, M.D., and Mark R. Gilbert, M.D.

Release Date: 02/22/2010

Upon completion of this Cyberounds^®, you should be able to:

Highlight pathways important in gliomagenesis
Discuss the current use of molecularly targeted agents for gliomas, as well as efficacy and adverse effects of treatment
Discuss the ongoing research using targeted agents in the treatment of gliomas.

Authors: Danilo De Gregorio, PharmD, Ph.D.

Several investigational agents offer hope to patients with AML.

Authors: Mary-Elizabeth M. Percival, M.D., M.S. and Roland B. Walter, M.D., Ph.D., M.S.

While some disorders are more readily apparent than others, not all bleeding is straightforward or has a readily identifiable cause.

Authors: Meera B. Chitlur, M.D.

Despite advances in lung cancer chemotherapy, there is a pressing need for effective lung cancer chemoprevention beyond smoking cessation.

Authors: Robert L. Keith, M.D.

Alcohol Abuse and Cancer